130 related articles for article (PubMed ID: 17634441)
41. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice.
Fukuda D; Sata M; Ishizaka N; Nagai R
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):90-6. PubMed ID: 17962627
[TBL] [Abstract][Full Text] [Related]
42. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice.
Ayabe N; Babaev VR; Tang Y; Tanizawa T; Fogo AB; Linton MF; Ichikawa I; Fazio S; Kon V
Atherosclerosis; 2006 Feb; 184(2):312-21. PubMed ID: 16023123
[TBL] [Abstract][Full Text] [Related]
43. Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.
Suen RS; Rampersad SN; Stewart DJ; Courtman DW
Am J Pathol; 2011 Sep; 179(3):1549-59. PubMed ID: 21718678
[TBL] [Abstract][Full Text] [Related]
44. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.
Braunersreuther V; Steffens S; Arnaud C; Pelli G; Burger F; Proudfoot A; Mach F
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1090-6. PubMed ID: 18388327
[TBL] [Abstract][Full Text] [Related]
45. Prevention of aortic elastic lamina defects by losartan in apolipoprotein(E)-deficient mouse.
Chan EC; Jones GT; Dusting GJ; Datla SR; Jiang F
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):919-24. PubMed ID: 19298535
[TBL] [Abstract][Full Text] [Related]
46. Vitamin E does not regress hypercholesterolemic atherosclerosis.
Prasad K
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):231-41. PubMed ID: 19498106
[TBL] [Abstract][Full Text] [Related]
47. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Takaya T; Kawashima S; Shinohara M; Yamashita T; Toh R; Sasaki N; Inoue N; Hirata K; Yokoyama M
Atherosclerosis; 2006 Jun; 186(2):402-10. PubMed ID: 16157344
[TBL] [Abstract][Full Text] [Related]
49. AT1 receptors and the actin cytoskeleton during angiotensin II treatment.
Bertels IM; Gontijo JA; Figueiredo JF
J Nephrol; 2007; 20(1):29-35. PubMed ID: 17347970
[TBL] [Abstract][Full Text] [Related]
50. [Ca2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro.
Wang Y; Wang W; Wang Q; Wu J; Xu J; Wu X
Biochem Biophys Res Commun; 2007 Dec; 364(1):118-23. PubMed ID: 17931598
[TBL] [Abstract][Full Text] [Related]
51. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
52. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I
Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777
[TBL] [Abstract][Full Text] [Related]
53. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-).
Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM
Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565
[TBL] [Abstract][Full Text] [Related]
54. Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm.
Moran CS; Cullen B; Campbell JH; Golledge J
J Vasc Res; 2009; 46(3):209-17. PubMed ID: 18931513
[TBL] [Abstract][Full Text] [Related]
55. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
56. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
[TBL] [Abstract][Full Text] [Related]
57. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S
PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
Guo RW; Yang LX; Wang H; Liu B; Wang L
Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
[TBL] [Abstract][Full Text] [Related]
59. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease.
Yamamoto T; Nakagawa T; Suzuki H; Ohashi N; Fukasawa H; Fujigaki Y; Kato A; Nakamura Y; Suzuki F; Hishida A
J Am Soc Nephrol; 2007 May; 18(5):1558-65. PubMed ID: 17409316
[TBL] [Abstract][Full Text] [Related]
60. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
Rodgers KJ; Watkins DJ; Miller AL; Chan PY; Karanam S; Brissette WH; Long CJ; Jackson CL
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
